Minority-Based Community Clinical Oncology Program Groups (U10)

archived

Purpose. This funding opportunity announcement solicits applications for the program known as Minority-Based Community Clinical Oncology Program (Minority-Based CCOP). This program allows practicing oncologists who serve large minority populations to participate in NCI-sponsored clinical trials. The purpose of this program is to support, as a national resource, research activities of physicians involved in the care of minorities who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials. The NCI clinical trials program supports CCOPs by providing access to clinical trials in cancer centers, major university centers, and community programs. The linkage of minority cancer patients/participants to the current clinical trials network facilitates the transfer of new research advancements in cancer prevention/control/treatment practices to minority communities and their physicians. The CCOP Network consists of three components each with its own FOA. The components are as follows: Minority Based-CCOPs (covered by this FOA), CCOP Groups (also referred to as CCOPs), and CCOP Research Bases. The Minority Based CCOPs are described in the previous paragraph. A Minority-Based CCOP encompasses community oncologists who accrue patients/participants to NCI-approved clinical trials. These trials are designed and conducted by the CCOP Research Bases, which also manage and analyze the data, and report the results. CCOP Research Bases must be located either at an NCI-supported Clinical Cooperative Group or at an NCI-designated Cancer Center. CCOP was established in 1983 to develop and conduct state-of-the-art cancer prevention, control and treatment clinical trials with significant involvement of community oncologists and populations they serve. The CCOP Network mission includes: (1) accelerating development of interventions to prevent and treat cancer and its symptoms by increasing accrual to trials; (2) fostering quality care in the community through adoption of results from clinical trials; and (3) increasing the involvement of minority and underserved patient/participant populations in cancer clinical trials and associated research. Mechanism of Support. This FOA will utilize the NIH U10 cooperative agreement award mechanism. Parallel FOAs (RFA-CA-10-010 and RFA-CA-10-011) solicit applications for Minority-Based CCOPs and CCOP Research Bases, respectively. It is imperative that Minority-Based CCOP applicants familiarize themselves with these parallel FOAs.

High